New York Senate Bill S05900

New York 2025-2026 Regular Session

• Introduced: 3/3/25
• Refer: 3/3/25
• Engrossed: 6/10/25
• Refer: 6/10/25
• Refer: 1/7/26
• Engrossed: 5/7/26
• Refer: 5/7/26
• Engrossed: 6/4/26
• Refer: 6/4/26

Caption

Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent abuse of prescription opioids.

Summary

S05900 amends the Mental Hygiene Law to direct the commissioner, using data already available to the office, to identify New York counties where prescription substance use disorder is most prevalent. In those counties, pharmacists licensed to dispense prescription drugs may be notified, at the commissioner’s discretion and in collaboration with the Department of Health, about the local prevalence of substance use disorder and may distribute educational materials created under the program. The bill is aimed at increasing public awareness and prevention efforts around the misuse of prescription drugs and addiction to prescription opioids. Rather than imposing new penalties or restricting dispensing practices, it creates a targeted outreach mechanism that uses pharmacists as a distribution point for educational materials in the counties most affected by prescription substance use disorder.

Impact

The bill would add a new paragraph to subdivision (j) of section 19.09 of the Mental Hygiene Law. Its practical effect is to authorize a county-targeted education initiative focused on prescription drug misuse and addiction, with the Office of Addiction Services and Supports and the Department of Health involved in identifying high-prevalence counties and supporting pharmacist notification. It does not create a mandate for pharmacists to distribute materials, but allows distribution at the commissioner’s discretion, making the program advisory and localized rather than regulatory.

Sentiment

The available voting history shows strong support and no recorded opposition. The bill passed the Senate Alcoholism and Substance Use Disorders Committee unanimously and later passed the Senate floor by a 58-0 vote, indicating broad bipartisan agreement on the need for prescription drug misuse education and opioid addiction prevention. The committee vote was also unanimous in a later recorded vote, reinforcing continued support.

Contention

There is little evidence of substantive controversy in the available materials. The main policy choice is whether to rely on targeted educational outreach through pharmacists in high-prevalence counties, rather than a statewide mandate or a more direct regulatory approach. Any potential concern would likely center on the commissioner’s discretion in selecting counties and deciding whether to notify pharmacists, but no opposing arguments or dissenting viewpoints are reflected in the votes or provided discussion.